03 August, 2026 | Monday | Expert Insight

As biologics, biosimilars, and advanced cell and gene therapies continue to reshape the Asia-Pacific biopharmaceutical landscape, manufacturers are under increasing pressure to enhance cold ch...

05 August, 2026 | Wednesday | Analysis

How this list was built Ten bottlenecks were identified from facility interviews, technical sessions at regional bioprocessing conferences and published case studies. Each entry pairs a constraint with...

04 August, 2026 | Tuesday | Interaction

BioPharma APAC speaks with Girisan Kariangal, Regional Vice President – Business Development & Alliance Management, Menarini Asia-Pacific, on the evolving opportunities and challenges of expanding acr...

07 August, 2026 | Friday | News

Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton...

10 August, 2026 | Monday | Opinion

Asia Pacific’s ageing economies are entering a more demanding phase of healthcare planning. As populations live longer, the challenge for healthcare systems is no longer only about extending life expectan...

05 August, 2026 | Wednesday | News

Christchurch-based Reform Radiology becomes inaugural clinical customer as New Zealand-developed photon-counting CT technology enters routine clinical practice Advanced photon-counting CT technology del...

10 August, 2026 | Monday | News

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the worl...